D J Fink

Author PubWeight™ 97.58‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 CD8(+) T cells can block herpes simplex virus type 1 (HSV-1) reactivation from latency in sensory neurons. J Exp Med 2000 3.62
2 Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994 3.14
3 Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 1998 2.35
4 Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. Science 1979 2.22
5 A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol 1994 1.86
6 Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activity. J Neurochem 1980 1.73
7 Innovative materials processing strategies: a biomimetic approach. Science 1992 1.72
8 HSV-mediated gene transfer of vascular endothelial growth factor to dorsal root ganglia prevents diabetic neuropathy. Gene Ther 2005 1.63
9 Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem 1999 1.62
10 Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain. J Virol 1994 1.51
11 PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant. J Virol 1994 1.45
12 An X Window system for statlab results reporting. Proc Annu Symp Comput Appl Med Care 1993 1.43
13 Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther 2001 1.41
14 Some thoughts on the nature of ectopic parathyroid hormones. Am J Med 1971 1.39
15 Gene transfer to interfere with TNFalpha signaling in neuropathic pain. Gene Ther 2007 1.37
16 Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons. Gene Ther 1998 1.36
17 In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia. J Clin Invest 1969 1.26
18 HSV-mediated transfer of interleukin-10 reduces inflammatory pain through modulation of membrane tumor necrosis factor alpha in spinal cord microglia. Gene Ther 2007 1.22
19 Biomineralization and eggshells: cell-mediated acellular compartments of mineralized extracellular matrix. Int Rev Cytol 1993 1.22
20 Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol 1995 1.22
21 Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture. J Virol 2000 1.20
22 Replication-defective herpes simplex virus vectors for gene transfer in vivo. Proc Natl Acad Sci U S A 1996 1.12
23 Serum cholesterol and primary brain tumours: a case-control study. Int J Epidemiol 1989 1.11
24 Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications. Gene Ther 1998 1.08
25 Rapid method for construction of recombinant HSV gene transfer vectors. Gene Ther 1997 1.06
26 Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR. J Virol 1996 1.06
27 Prolonged preservation of nerve function in diabetic neuropathy in mice by herpes simplex virus-mediated gene transfer. Diabetologia 2007 1.05
28 Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: results from the first screening cycle (1998-2000). J Clin Endocrinol Metab 2006 1.01
29 Rapid construction of deleted DNA fragments for use as internal standards in competitive PCR. PCR Methods Appl 1994 0.98
30 Differential distribution of (Na, K)-ATPase alpha isoforms in the central nervous system. Cell Mol Neurobiol 1991 0.97
31 S100 is preferentially distributed in myelin-forming Schwann cells. J Neurocytol 1990 0.97
32 Engineering herpes simplex virus vectors for CNS applications. Exp Neurol 1999 0.97
33 A human trial of HSV-mediated gene transfer for the treatment of chronic pain. Gene Ther 2009 0.95
34 HveC (nectin-1) is expressed at high levels in sensory neurons, but not in motor neurons, of the rat peripheral nervous system. J Neurovirol 2001 0.95
35 Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol 1999 0.95
36 Intermolecular interactions in collagen self-assembly as revealed by Fourier transform infrared spectroscopy. Science 1983 0.94
37 Epidemiologic factors affecting antimicrobial resistance of common bacterial isolates. J Clin Microbiol 1987 0.93
38 Gene therapy progress and prospects: Parkinson's disease. Gene Ther 2003 0.93
39 Phosphorylation-dependent neurofilament epitopes are reduced at the node of Ranvier. J Neurocytol 1992 0.92
40 Prevalence of use of cocaine and other substances in an obstetric population. Am J Obstet Gynecol 1990 0.92
41 Cytochemical localization of Ca2+-ATPase activity in peripheral nerve. Brain Res 1988 0.92
42 Bcl-2 and GDNF delivered by HSV-mediated gene transfer act additively to protect dopaminergic neurons from 6-OHDA-induced degeneration. Exp Neurol 2001 0.92
43 Herpes simplex virus vector-mediated expression of Bcl-2 prevents 6-hydroxydopamine-induced degeneration of neurons in the substantia nigra in vivo. Proc Natl Acad Sci U S A 1999 0.92
44 Immunocytochemical demonstration of Na+,K(+)-ATPase in internodal axolemma of myelinated fibers of rat sciatic and optic nerves. J Neurochem 1991 0.91
45 The avian eggshell extracellular matrix as a model for biomineralization. Connect Tissue Res 1996 0.91
46 MR imaging of brachial plexopathy in neurolymphomatosis. AJR Am J Roentgenol 1997 0.89
47 Differential distribution of (Na,K)-ATPase alpha isoform mRNAs in the peripheral nervous system. Brain Res 1991 0.88
48 Disease pattern recognition testing for rheumatoid arthritis using infrared spectra of human serum. Clin Chim Acta 2001 0.88
49 Serum cholesterol levels in adenomatous polyps and cancer of the colon. A case-control study. JAMA 1986 0.87
50 Changes in intra-axonal calcium distribution following nerve crush. J Neurobiol 1986 0.86
51 Cerebral atrophy in young cannabis smokers. Lancet 1972 0.86
52 Cancer overview. Cancer Res 1979 0.85
53 Distribution of albumin-like immunoreactivity in rat sciatic nerve after nerve crush injury. J Neuropathol Exp Neurol 1988 0.85
54 Retrograde axonal transport of endogenous proteins in sciatic nerve demonstrated by covalent labeling in vivo. Science 1980 0.84
55 Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells 2001 0.83
56 Axotomy increases CNTF receptor mRNA in rat spinal cord. Brain Res 1993 0.83
57 Transgene-mediated expression of tumor necrosis factor soluble receptor attenuates morphine tolerance in rats. Gene Ther 2011 0.83
58 Ultrastructural distribution of Ca++ within neurons. An oxalate pyroantimonate study. Histochemistry 1987 0.83
59 cis-acting elements involved in transcriptional regulation of the herpes simplex virus type 1 latency-associated promoter 1 (LAP1) in vitro and in vivo. J Virol 1996 0.83
60 The use of a labeled acylating probe for the study of fast axonal transport, in vivo. Brain Res 1979 0.82
61 Prolonged regulatable expression of EPO from an HSV vector using the LAP2 promoter element. Gene Ther 2011 0.82
62 A direct electron microscopic immunocytochemical study of IgM paraproteinemic neuropathy. Arch Neurol 1988 0.82
63 The distribution of serum albumin in rat peripheral nerve. J Neuropathol Exp Neurol 1987 0.81
64 Routine chest x-ray films in a Veterans Hospital. JAMA 1981 0.81
65 Herpes simplex virus vectors for gene transfer to the nervous system. J Neurovirol 1997 0.81
66 Gene therapy for pain: introduction to the special issue. Gene Ther 2009 0.80
67 Deletion of the S component inverted repeat sequence c' and the nonessential genes U(S)1 through U(S)5 from the herpes simplex virus type 1 genome substantially impairs productive viral infection in cell culture and pathogenesis in the rat central nervous system. J Neurovirol 1997 0.80
68 Ca++-ATPase in the central nervous system: an EM cytochemical study. J Histochem Cytochem 1989 0.80
69 Addressing the needs and solutions to increase the use of low-cost screening mammography. Cancer 1987 0.80
70 Herpes simplex virus vectors and gene transfer to brain. Dev Biol Stand 1994 0.80
71 Drug inducible transgene expression in brain using a herpes simplex virus vector. Gene Ther 1998 0.79
72 Evidence for slow retrograde transport of serum albumin in rat sciatic nerve. Brain Res 1982 0.79
73 Gene transfer to brain using herpes simplex virus vectors. Ann Neurol 1994 0.78
74 Vector-mediated expression of erythropoietin improves functional outcome after cervical spinal cord contusion injury. Gene Ther 2011 0.78
75 Axonal transport of proteins. A new view using in vivo covalent labeling. J Cell Biol 1980 0.78
76 beta,beta'-Iminodipropionitrile impairs retrograde axonal transport. J Neurochem 1986 0.78
77 Spectroscopic probes of blood-surface interaction. Trans Am Soc Artif Intern Organs 1983 0.78
78 Herpes simplex virus vector-mediated expression of Bcl-2 protects spinal motor neurons from degeneration following root avulsion. Exp Neurol 2001 0.78
79 Serum haptoglobin. A valuable diagnostic aid in suspected hemolytic transfusion reactions. JAMA 1967 0.77
80 Engineering herpes simplex virus vectors for human gene therapy. Adv Pharmacol 1997 0.77
81 Modulation of phosphorylation of neuronal cytoskeletal proteins by neuronal depolarization. Cell Mol Neurobiol 1997 0.77
82 A new player in gene therapy for pain? Gene Ther 2008 0.77
83 Activity-dependent regulation of Na+, K(+)-ATPase alpha isoform mRNA expression in vivo. J Neurochem 1992 0.77
84 Formation of synaptic endings by colossal fibers in the vestibular epithelium of the chick embryo. Neuroscience 1977 0.77
85 Facts about colorectal cancer detection. CA Cancer J Clin 1984 0.77
86 Refractory normoblastic ("sideroblastic") anemia. Clinical and electron microscopic observations. Am J Clin Pathol 1966 0.76
87 An orally administered microcapsule system for treating chronic renal failure patients. Appl Biochem Biotechnol 1984 0.76
88 Alterations in retrograde axonal transport in streptozocin-induced diabetic rats. Diabetes 1987 0.76
89 Calmodulin distribution in peripheral nerve: an EM immunocytochemical study. Brain Res 1988 0.76
90 In vivo transgene activation from an HSV-based gene therapy vector by GAL4:vp16. Gene Ther 1996 0.75
91 Gene therapy for Canavan disease? Ann Neurol 2000 0.75
92 Calpain II in rat peripheral nerve. Brain Res 1991 0.75
93 HSV as a gene transfer vector for the nervous system. Mol Biotechnol 1995 0.75
94 Development of herpes simplex virus as a gene transfer vector for the nervous system. Gene Ther 1994 0.75
95 Exposure to agent orange. JAMA 1980 0.75
96 Developing marketing strategies for university teaching hospitals. J Med Educ 1980 0.75
97 Housestaff are employees. Bull Am Coll Physicians 1977 0.75
98 Scientific book prices. J Med Educ 1981 0.75
99 Book prices. J Med Educ 1973 0.75
100 Progress in genitourinary cancer. Cancer 1987 0.75
101 Differential axonal transport of individual Na,K-ATPase catalytic (alpha) subunit isoforms in rat sciatic nerve. Brain Res 1993 0.75
102 Assessment of thyroxine by enzyme immunoassay with the ABA-100 analyzer. Clin Chem 1978 0.75
103 Analysis of HSV-DNA and RNA Using the Polymerase Chain Reaction. Methods Mol Med 1998 0.75
104 Consensus conference on screening for lung cancer. Vet Hum Toxicol 1979 0.75
105 6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study. Cancer Chemother Rep 1970 0.75
106 A quantitative study of retrograde axonal transport in motor and sensory neurons. Brain Res Bull 1986 0.75
107 Multiple-rate components of axonally transported proteins in the hypothalamo-neurohypophysial system of the rat. J Neurobiol 1981 0.75
108 Rapid retrograde transport of proteins in sensory neurons in rats. Brain Res 1985 0.75
109 The physician's stake in health care marketing. Hosp Med Staff 1981 0.75
110 Crystallization studies on avian eggshell membranes: implications for the molecular factors controlling eggshell formation. Matrix Biol 1995 0.75
111 Health care crisis. Science 1971 0.75
112 Ultrastructural localization of slow retrograde axonal transport: an autoradiographic study. J Neurosci 1985 0.75
113 The first year: trial by fire. J Med Educ 1972 0.75
114 Cooperative clinical investigation. A modality of medical science. JAMA 1974 0.75
115 A population-based study of referral, diagnostic and treatment patterns for childhood acute lymphocytic leukemia. Am J Epidemiol 1977 0.75
116 Immunologic detection of prostatic acid phosphatase: critique II. Hum Pathol 1978 0.75
117 Creatine kinase activity in spinal fluid. Clin Chem 1977 0.75
118 Cancer prevention and control by the American Cancer Society. Prog Clin Biol Res 1983 0.75
119 The 'Me Generation' meets medical practice. Am Coll Physicians Obs 1982 0.75
120 Management for physicians: an annotated bibliography of recent literature. Ann Intern Med 1980 0.75
121 Quantitative surface studies of protein adsorption by infrared spectroscopy. I. Correction for bulk concentrations. Anal Biochem 1984 0.75
122 Letter: Screening for breast cancer. Lancet 1976 0.75
123 Obstacles to effective professional education programming by a voluntary health association: findings from a national survey. J Cancer Educ 1988 0.75
124 Overproduction health professionals. N Engl J Med 1971 0.75
125 Letter: Screening by mammography. N Engl J Med 1976 0.75
126 Predictive value of the uptake of 86 Rb by erythrocytes of control and cancer subjects using a computer programmed discrimination technique. Res Commun Chem Pathol Pharmacol 1971 0.75
127 The Cancer Control Program. Cancer 1975 0.75
128 Technology assessment: then and now. N Engl J Med 1981 0.75
129 Introduction to the workshop on fat and cancer. Cancer Res 1981 0.75
130 Drug treatment of anxiety. Lancet 1972 0.75
131 Pneumoconiosis and fibrous glass. Am Ind Hyg Assoc J 1979 0.75
132 Career paths of physicians who received an American Cancer Society Regular Clinical Fellowship. Cancer 1988 0.75
133 Pediatric cancer and nutrition workshop: introductory comments. Cancer Res 1982 0.75